Literature DB >> 10462278

The predictive value of cardiac troponin T measurements in subjects on regular haemodialysis.

J C Stolear1, B Georges, A Shita, D Verbeelen.   

Abstract

BACKGROUND: Cardiac troponin T (cTnT) is a subunit of the cardiac actin-myosin complex, which leaks into the circulation when myocardial necrosis is present. Detection of cTnT is associated with a poor outcome in patients with unstable angina, and is a useful tool for risk stratification. The value of cTnT determination in patients with renal failure has been questioned, and the specificity of cTnT in this particular group has not been established.
METHODS: In the present study, 94 patients at a single centre were followed prospectively after three determinations of cTNT, at 1-month intervals. The outcome after 12 months was chosen as the end-point. cTnT was measured using both a quantitative chemiluminiscence immunoassay and a qualitative rapid bedside immunoassay on a test strip. The maximum of three measurements was used and was correlated with different parameters and outcome. The following statistical tests were performed: Kaplan-Meier analysis, Cox's proportional regression analysis for measuring survival and logistic regression for analysing factors influencing cTnT.
RESULTS: Forty seven of the 94 patients had a positive cTnT by test strip defined as >0.10 ng/ml. Twenty four patients died in the follow-up period (14 from cardiovascular causes). Twenty of the 24 non-survivors had an increased cTnT by test strip and 23 had increased cTnT by laboratory immunoassay. The outcome analysed by a Cox's proportional regression analysis showed that the factors which influenced survival significantly were cTnT, the presence of ischaemic heart disease, C-reactive protein (CRP) and prealbumin. A logistic multivariate analysis revealed that age and CRP significantly influenced cTnT. A good correlation was found between cTnT determined by test strip and in the laboratory.
CONCLUSION: cTnT is elevated in a large number of patients on regular haemodialysis and is a significant independent predictor of outcome. Increased cTnT is significantly predicted by age and CRP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462278     DOI: 10.1093/ndt/14.8.1961

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

Review 1.  Troponin: the biomarker of choice for the detection of cardiac injury.

Authors:  Luciano Babuin; Allan S Jaffe
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

2.  Effect of hemodialysis on traditional and innovative cardiac markers.

Authors:  Martina Montagnana; Giuseppe Lippi; Nicola Tessitore; Gian Luca Salvagno; Giovanni Targher; Matteo Gelati; Antonio Lupo; Gian Cesare Guidi
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

3.  Plasma levels of brain natriuretic peptides and cardiac troponin in hemodialysis patients.

Authors:  Halima Resić; Selma Ajanović; Nihad Kukavica; Fahrudin Masnić; Aida Corić
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

Review 4.  Cardiac troponins I and T: molecular markers for early diagnosis, prognosis, and accurate triaging of patients with acute myocardial infarction.

Authors:  Ram P Tiwari; Anubhav Jain; Zakir Khan; Veena Kohli; R N Bharmal; S Kartikeyan; Prakash S Bisen
Journal:  Mol Diagn Ther       Date:  2012-12       Impact factor: 4.074

Review 5.  Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: a meta-analysis.

Authors:  Wei-Jie Li; Xu-Miao Chen; Xiao-Ying Nie; Jing Zhang; Yun-Jiu Cheng; Xiao-Xiong Lin; Su-Hua Wu
Journal:  Clinics (Sao Paulo)       Date:  2015-04       Impact factor: 2.365

6.  Sensitive troponins--which suits better for hemodialysis patients? Associated factors and prediction of mortality.

Authors:  Ferruh Artunc; Christian Mueller; Tobias Breidthardt; Raphael Twerenbold; Andreas Peter; Claus Thamer; Peter Weyrich; Hans-Ulrich Haering; Bjoern Friedrich
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.